CompletedPhase 3

Meditation for Depression and Anxiety Symptoms in Dialysis Patients

Canada50 participantsStarted 2016-03

Plain-language summary

This study examines the use of brief meditation interventions for patients with symptoms of anxiety and depression who are undergoing dialysis. Half of the participants will receive meditation interventions 3 times a week, while the other half will receive treatment as usual. This study will examine whether meditation is feasible and whether it has any effect on reducing symptoms of anxiety or depression.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients currently receiving maintenance hemodialysis * Patients with depression and/or anxiety as indicated by scores of ≥10 on the Patient Health Questionnaire (PHQ-9) and/or General Anxiety Disorder-7 (GAD- 7) * Normal cognition or Mild Cognitive Impairment ("Normal" Result on the 3-minute Mini-Cog Test) Exclusion Criteria: * Mild, Moderate, or Severe Dementia ("Abnormal" Result on the 3-minute Mini-Cog Test) * Acute psychotic symptoms * Acute Suicidal ideation/intent

What they're measuring

Proportion of participants screened as eligible who enroll

Timeframe: 34 months

Proportion of participants who enrolled who completed the 8 week-trial

Timeframe: 34 months

Tolerability of Meditation Intervention on a 10-point Likert scale

Timeframe: 8 weeks

Trial details

NCT IDNCT02686333

SponsorLady Davis Institute

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-12-01

View on ClinicalTrials.gov More Depression trials